Effect of seasonal vaccination on the selection of influenza A/H3N2 epidemic variants (Q39129072)

9 September 2017

title

Effect of seasonal vaccination on the selection of influenza A/H3N2 epidemic variants (English)

1 reference

9 September 2017

Yong Chong

1

1 reference

9 September 2017

Hideyuki Ikematsu

series ordinal

2

1 reference

9 September 2017

language of work or name

English

0 references

publication date

2 December 2016

1 reference

9 September 2017

1 reference

9 September 2017

volume

35

1 reference

9 September 2017

issue

2

1 reference

9 September 2017

page(s)

255-263

1 reference

Influenza vaccine: the challenge of antigenic drift.

9 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.11.084

Vaccination and antigenic drift in influenza

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.11.084

Variable influenza vaccine effectiveness by subtype: a systematic review and meta-analysis of test-negative design studies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.11.084

Enhanced Genetic Characterization of Influenza A(H3N2) Viruses and Vaccine Effectiveness by Genetic Group, 2014-2015.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.11.084

Antibody titer has positive predictive value for vaccine protection against challenge with natural antigenic-drift variants of H5N1 high-pathogenicity avian influenza viruses from Indonesia.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.11.084

Experimental challenge of chicken vaccinated with commercially available H5 vaccines reveals loss of protection to some highly pathogenic avian influenza H5N1 strains circulating in Hong Kong/China

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.11.084

Evidence for differing evolutionary dynamics of A/H5N1 viruses among countries applying or not applying avian influenza vaccination in poultry

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.11.084

Deep Sequencing Reveals Potential Antigenic Variants at Low Frequencies in Influenza A Virus-Infected Humans.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.11.084

A prospective, Internet-based study of the effectiveness and safety of influenza vaccination in the 2001–2002 influenza season

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.11.084

Factors influencing the effectiveness of oseltamivir and amantadine for the treatment of influenza: a multicenter study from Japan of the 2002-2003 influenza season

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.11.084

A comparison of the effectiveness of oseltamivir for the treatment of influenza A and influenza B: a Japanese multicenter study of the 2003-2004 and 2004-2005 influenza seasons.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.11.084

Clinical effectiveness of oseltamivir and zanamivir for treatment of influenza A virus subtype H1N1 with the H274Y mutation: a Japanese, multicenter study of the 2007-2008 and 2008-2009 influenza seasons

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.11.084

In vitro neuraminidase inhibitory activity of four neuraminidase inhibitors against influenza virus isolates in the 2011-2012 season in Japan

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.11.084

In vitro neuraminidase inhibitory activity of four neuraminidase inhibitors against clinical isolates of influenza virus in the Japanese 2012-2013 season

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.11.084

Single-reaction genomic amplification accelerates sequencing and vaccine production for classical and Swine origin human influenza a viruses.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.11.084

MEGA6: Molecular Evolutionary Genetics Analysis version 6.0

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.11.084

Low 2012-13 influenza vaccine effectiveness associated with mutation in the egg-adapted H3N2 vaccine strain not antigenic drift in circulating viruses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.11.084

Structural identification of the antibody-binding sites of Hong Kong influenza haemagglutinin and their involvement in antigenic variation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.11.084

Substitutions near the receptor binding site determine major antigenic change during influenza virus evolution

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.11.084

Simultaneous amino acid substitutions at antigenic sites drive influenza A hemagglutinin evolution

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.11.084

Efficacy of high-dose versus standard-dose influenza vaccine in older adults

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.11.084

Prediction, dynamics, and visualization of antigenic phenotypes of seasonal influenza viruses.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.11.084

Multiplex PCR for typing and subtyping influenza and respiratory syncytial viruses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.11.084

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/J.VACCINE.2016.11.084

1 reference

9 September 2017

1 reference